The US Food and Drug Administration (FDA) has approved Nuvation Bio’s Ibtrozi (taletrectinib) to treat adults with a rare and ...

These are the first clinical study results for the drug in a large population of patients with darker skin tones ...

That is why global cooperation is so crucial to rare disease research. National, international and community partnerships and ...

Alongside the data in PsA, UCB will present at EULAR new results demonstrating that Bimzelx delivered sustained clinical ...

NewAmsterdam Pharma has shared promising Alzheimer’s disease (AD) biomarker data from a late-stage study of its ...

Galderma has shared positive two-year data for its monoclonal antibody Nemluvio (nemolizumab) in moderate-to-severe atopic ...

Today, by contrast, the marketers I study complain of being swamped by data and confused by information overload. And when I ...

Results from the study’s open-label period, presented at this year’s European Renal Association Congress, showed that ...

Merck & Co – known as MSD outside the US and Canada – has announced that its respiratory syncytial virus (RSV) preventive ...

Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) has been approved by the European Commission (EC) to treat adults with ...

The PM (Pharmaceutical Marketing) Society is delighted to announce a new partnership with the CIM (Chartered Institute of ...

By combining different treatment options – especially those involving immuno-oncology (IO) – researchers aim to develop ...